To answer this question, it is first worth taking a look at the chart.

The share has lost around 45% since its high of around €590 and is currently trading at €317. If the question arises as to why the share has been sold off so strongly, this is due to a real exaggeration on the upside, which in my view has caused an exaggeration on the downside. You can see how, according to the share finder, it was well above fair value for a long time. Recently, however, it has come back significantly.

$6861 (+4,23%)

1. the "fabless" miracle: assets without ballast

Keyence develops sensors, microscopes and vision systems for factory automation. Yet they do not own a single factory.

- The effect: they have almost no tied-up capital (asset-light). If the economy falters, they do not have to close any factories or lay off workers.

2 The direct sales monopoly

Normally, companies sell through intermediaries. Keyence does the opposite:

- On-site problem solvers: Keyence engineers go directly to customers' factories. They don't just sell a product from the catalog, but solve a specific problem (e.g.: "How do I detect this micro-crack at 200 km/h belt speed?").

- Pricing power: Since they offer a solution that saves the customer millions in downtime costs, the price of the sensor hardly plays a role. This leads to a gross margin of over 80%.

This is the biggest moat there is. They have a virtual monopoly in this area of automation and problem solving.

The EBIT margin is a legendary 53% and the net income margin is around 37%. This means that almost half of every euro of turnover remains as pure profit. And that for an industrial company.

The current P/E ratio is around 30, which is 7.68 points below the historical average of 37.68 for the last 10 years. The 5-year average is even 45. From this perspective, the Keyence share appears to be reasonably valued.

favorably valued from this perspective.

Keyence is also sitting on a high cash mountain and is practically debt-free.

What about the risks?

China exposure & geopolitics

Keyence is heavily dependent on the global propensity to invest.

- Problem: A significant proportion of sensors end up in Chinese factories (e-car production, batteries, electronics). If the trade conflict between the USA and China escalates in 2026 or China makes access for foreign high-tech even more difficult, Keyence will be directly affected.

- Currency risk: The weak yen has visually inflated profits. If the yen appreciates massively in 2026 (e.g. due to interest rate hikes by the Bank of Japan), foreign income will be lower when converted into yen.

Opportunities:

The labor shortage.

This is the biggest opportunity for Keyence. In almost all industrialized nations (Japan, Germany, USA) and even in China, the working population is shrinking.

- From "nice-to-have" to "must-have": in 2026, companies will no longer automate just to save costs, but because they can no longer find people.

- Keyence advantage: As Keyence sensors are extremely easy to install, companies can automate their factories faster than with the complex individual solutions of the competition.

Scalability: Since Keyence has no factories, they can roll out software updates for their AI sensors worldwide and charge subscription fees or higher margins. This makes the business model even more "software-like".

Finally, if we look at the heuristics, the following picture emerges.

The majority of analysts also recommend buying with a premium of almost 30% to the average price target.

Conclusion: I personally see Keyence as a good stock for diversification. The margins are also outstanding and you are still buying a quality company at a high price, albeit well below its historical average. Looking at the heuristics, my model also shows a good risk/return ratio. I don't think you can do much wrong with the share, as the company has a huge cash reserve and also holds a monopoly-like position in Japan.

What do you think of the company? Are you already invested?

Feel free to write your opinion, also with regard to the current market risks.

@Tenbagger2024
@Get_Rich_or_Die_Tryin
@Raketentoni
@PikaPika0105 etc......

Hello to the GQ community ✌️

My first post after being kicked about 4 weeks ago - who would have thought that solidarity towards one of the members (@Klein-Anleger ) would lead to a ban so quickly? But the goodwill of getquin was so BIG (and above all "on trial") that they graciously let me back into the holy grail of the GQ community 😉

So guys, learn from my mistakes: the goodwill here is not an Infinite Money glitch ! Save your solidarity, reduce your commitment to other members to zero and the most important thing 🚨: No surreptitious advertising for alternative financial platforms like "Cisdord" 😉😂.

Sorry, the side blow after 4 weeks of abstinence had to be 🤝

so joking aside...

⏳The first three months of 2026 have passed. Time for a brief interim summary of the current status of my reconstruction.

Before I started rebuilding the portfolio, I naturally thought about what strategy I wanted to pursue in the coming months and years - especially with regard to stock selection and weighting.

To be honest, my original plan was to keep a portfolio with a maximum of 20 shares. In the course of time, however, I realized that it will probably not stay at 20 stocks, but that the number is more likely to increase to around 30 positions (+/-).

♟️Mein Focus & my strategy:

In a nutshell: The clear focus is on growth 🚀. Dividends tend to play a subordinate role. Here I show you my shopping list and what my portfolio should look like in the future. The stocks I have already bought are marked with a green tick and without a tick, I'm still waiting ⏳

🤖TECH:

• AMAZON $AMZN (+1,45%) ✅
• MICROSOFT $MSFT (-0,39%) ✅
• CROWDSTRIKE $CRWD (+0,16%) ✅
• SYNOPSYS $SNPS (+0,28%) ✅
• INTUIT $INTU (-2,55%) ✅
• CONSTELLATION SOFTWARE $CSU (+0,59%) ✅
• SERVICENOW $NOW (-0,95%) ✅
• ALPHABET $GOOGL (+3,67%)
• NVIDIA $NVDA (+0,58%)
• ASML $ASML (+3,73%)
• MONOLITHIC POWER SYSTEMS $MPWR (+2,03%)
• ARISTA NETWORKS $ANET (+2,22%)
• KEYENCE $6861 (+4,23%) ✅
• TSMC $TSM (+1,37%)
• 
  MARUWA $5344 (+5,13%)
• LASERTEC CORP $6920

🏦💸FINANCE:

• SOFI TECHNOLGIES $SOFI (-1,49%) ✅
• S&P GLOBAL $SPGI (-0,2%) ✅
• VISA $V (-1,19%) ✅
• MUNICH RE $MUV2 (-0,46%) ✅
• GERMAN EXCHANGE $DB1 (-0,34%) ✅
• PARTNERS GROUP $PGHN (+1,19%) ✅
• BROOKFIELD CORP $BN (+0,57%) ✅
• HOULIHAN LOKEY $HLI (-0,6%) ✅
• BROADRIDGE $BR (-1,42%) ✅
• CBOE GLOBAL MARKETS $CBOE (+0%)

🏥🩻HEALTHCARE:

• NOVO NORDISK $NOVO B (-0,26%) ✅
• INTUITIVE SURGICAL $ISRG (+1,02%)
• STRYKER $SYK (-0,3%)
• BOSTON $BSX (-0,74%)

🏭🏗️INDUSTRIE & REST:

• WASTE MANAGEMENT $WM (-0,02%) ✅
• GRAB HOLDINGS $GRAB (+0,47%) ✅
• CINTAS $CTAS (+1,62%) ✅
• MonotaRO $3064 ✅
• ITOCHU $8001 (+1,76%) ✅
• HERMES $RMS (+2,68%) ✅
• MERCADOLIBRE $MELI (-0,4%) ✅

------------------------

this is my extended watchlist:

IN TECH:

RAMBUS $RMBS (+3,99%) , QNITY ELECTRONICS $Q (+3,59%) ,

INNODATA $INOD (+4,75%) , NETFLIX $NFLX (-0,82%) ,

VERTIV $VRT (+4,16%) , PALANTIR $PLTR (-0,14%) , VAT GROUP $VACN (+0,86%) , BROADCOM $AVGO (+1,04%)

FINANCE:

APOLLO GLOBAL $APO (-0,77%) / BLACKSTONE $BX (-0,92%) , ALLIANZ $ALV (+1,46%) , FIRSTCASH $FCFS (+0,54%) , BLACKROCK $BLK (+0,44%)

HEALTHCARE:

CATALYST PHARM $CPRX (-0,02%) , MERIT MEDICAL SYSTEMS $MMSI (-0,41%) , REGENERON PHARM $REGN (-0,24%) , UFP TECHNOLOGIES $UFPT (+0,74%) , WEST PHARM $WST (+0,85%)

REST:

MISUMI GROUP $9962 (+3,39%) , KANEMATSU $8020 (+3,28%) , APPLIED INDUSTRIAL TECH $AIT (+1,75%) , BADGER METER $BMI (+1,97%) , HUNTINGTON INGALLS INDUSTRIES $HII (+3,79%) , INSTULL BUILDING PRODUCTS $IBP (+3,49%) , CEMENT ROADSTONE HOLDING $CRH (+1,71%)

This is not yet my final stock selection/watchlist. Of course, there can always be changes, e.g. if the @Tenbagger2024 continues to present such undiscovered gems 🙏🏽🧐

------------------------

What should the sector/country weighting look like?

Let's start with the "desired"

🌍country weighting:

🇺🇸🇨🇦USA ~60%

🇪🇺EUROPA ~20%

🇯🇵JAPAN/ASIA ~15%

Rest ~5%

Sector weighting should be as follows:

💻TECHNOLOGY: ~30-35%

💸FINANCE: ~ 20-25%

HEALTHCARE: ~ 10-15%

🏭INDUSTRY: ~ 10-15%

REST: ~ 5-10%

So, what has happened since the beginning of the year?

Of course there were no sales 😬

There have been a few purchases where I have a finger in the pie.

JANUARY PURCHASES

$INTU (-2,55%)
$GRAB (+0,47%)
$NOW (-0,95%)
$MSFT (-0,39%)

FEBRUARY PURCHASES

$NOW (-0,95%)
$INTU (-2,55%)
$SPGI (-0,2%)
$SNPS (+0,28%)
$CSU (+0,59%)
$SOFI (-1,49%)
$CRWD (+0,16%)

MARCH PURCHASES

$MUV2 (-0,46%)
$3064
$8001 (+1,76%)
$6861 (+4,23%)
$DB1 (-0,34%)
$V (-1,19%)
$HLI (-0,6%)
$MSFT (-0,39%)
$CTAS (+1,62%)
$MELI (-0,4%)
$BN (+0,57%)
$PGHN (+1,19%)
$BR (-1,42%)

Due to the global political situation - especially because of this 🍊 in the White House, whose tweets cause more tsunamis 🌊than real natural disasters - and the current drawdown in the S&P 500 (which is very convenient for me right now and gives me a lot of pleasure 🤩), I am accordingly under water💦🫧 with some of my purchases so far.

but hey, we're investing for the long term, aren't we? So easy going, all relaxed 🥱 I will most likely not make any more purchases in the next few days or weeks, park my cash position elsewhere or put it in overnight money and wait and see which zone the market settles in or wait for it to stabilize.

What do you have on your watchlist?

Are you currently waiting or how are you dealing with the current situation?

@Get_Rich_or_Die_Tryin
@Tenbagger2024
@Max095 and of course all other members

Ok, that's enough now 😂

that's it from me for now ✌️

your stock master

February was a challenging and volatile month.

A strong start to the year was followed by a significant sector-rotationtriggered by risk-off-flowsa reassessment of growth stocks and the need to consistently address operational weaknesses in the portfolio.

Despite the volatility, it was a month of strategic realignment:

📊 Monthly performance: -3,15%

📊 Portfolio value: ~39.144 €

📊 Performance max: +27,58%

📊 Performance YTD: -1,32%

Performance & comparison 🚀

February was characterized by a clear sector rotation:

Software & high-beta tech corrected under pressure, while selected hardware stocks and broadly diversified value stocks showed relative stability.

Performance in comparison (01.02-28.02.2026):

My portfolio: -3,48%

NASDAQ 100: -4,05%

S&P 500: -1,29%

DAX: +1,03%

FTSE All-World: +0,97%

👉 The relative underperformance is due to the high growth exposure, although the portfolio just managed to outperform the NASDAQ 100, which was under heavy pressure.

Purchases, sales & allocation 💶

The focus in February was clearly on portfolio streamlining and strategic shift:

Acquisitions 💰

Hermes ($RMS (+2,68%)) targeted expansion in the quality segment. TSMC ($2330) tactical entry due to the observed shift on the stock market from software to hardware. Bitcoin ($BTC (-0,29%)) - purchase of € 500 from the Euro Overnight Rate Swap ETF ($XEON (+0%)) at € 54,216 to lower the average price to € 63,000.

Sales ❌

Complete separation of Tomra Systems ($TOM (+0,58%)) and Novo Nordisk ($NOVO B (-0,26%)), as the companies have been operationally disappointing in recent quarters and there were no clear signs of a turnaround from management.

👉 The cash ratio is currently being used dynamically for opportunities through targeted acquisitions.

Top movers in February 🟢

Despite the market environment, February was driven by quality stocks and successful rebounds.

The strongest performer was Keyence ($6861 (+4,23%)), which showed massive relative strength with +16.21%. Another strong performer was Ferrari ($RACE (+1,09%)) was also strong with +13.45%, followed by Berkshire Hathaway ($BRK.B (-0,04%)), which acted as a stable anchor with +6.22%.

The iShares MSCI World Small Cap ($WSML (+1,52%)) gained +3.61%, while the iShares MSCI ACWI ($ACWI) formed a solid base with +0.70%. The Xtrackers II EUR Overnight Rate ($XEON (+0%)) rounded off the picture with +0.15% and served as a source for the Bitcoin investment.

Flop movers in February 🔴

The weaker side of the portfolio was clearly to be found in the growth and crypto segment.

IREN ($IREN (-0,52%)) corrected by -24.10% after the strong previous month. Also Mercado Libre ($MELI (-0,4%)) also came under significant pressure at -17.33%. CrowdStrike ($CRWD (+0,16%)) -16.94% and Snowflake ($SNOW (+2,16%)) -16.36% suffered from the general shift in sentiment in the software sector.

Also Alibaba ($BABA (-1,66%)) also gave back the gains of the previous month with -16.02%. Nubank ($NU (+1,94%)) rounded off the list of losers with -15.90% due to the poor sentiment among payment providers.

👉 Important: These are primarily valuation and sentiment moves, not fundamental breaks - nevertheless, the lack of operational momentum made it necessary to sell positions.

Conclusion 💡

February was not an easy month, but a necessary for rebalancing:

➡️ Strategic separation of stocks without operational momentum

➡️ Focus shiftFrom software/high growth to hardware (TSMC) and focus on quality (Hermes)

➡️ Volatility deliberately used to lower the average Bitcoin price

The environment remains challenging:

Interest rates, Fed expectations and the rotation into hardware stocks will continue to shape the markets in March. The focus remains on quality, operational excellence and liquidity.

❓ Question for the community

Which stock surprised you the most in February - positively or negatively?

👇 Write it in the comments!

Keyence ($6861 (+4,23%)) is not a classic hardware trade, but a structural bet on the total automation of global industry and its unstoppable need for efficiency.

Industrial automation is only the tool here. The real value comes from a unique fabless model, radical direct sales and unrivaled pricing power. pricing power.

Margin instead of mass, problem solving instead of product sales, cash flow instead of capital commitment.

⚙️ What does Keyence do?

➡️ Core Business & FA (factory automation):

World market leader in sensors, measuring systems and machine vision solutions. Keyence provides the "eye and brain" of the modern smart factory. The products are essential for autonomous production.

→ Technology leadership + Indispensability.

➡️ The fabless model:

Keyence does not produce itself. By outsourcing production, the company makes massive CapEx savings and remains extremely agile. The capital flows primarily into R&D and sales.

→ Maximum scalability + asset-light structure.

➡️ Direct sales as a moat:

No middlemen. middlemen. Highly specialized engineers advise customers directly on site at the factory. This creates deep trust and secures the highest margins in the entire industry.

→ Deep customer understanding + enormous pricing power.

➡️ The innovation machine:

Over 70% of new releases are world firsts. Keyence anticipates industry problems before customers have even identified them themselves.

→ continuous competitive edge + high barriers to market entry.

📊 Figures & growth (Q3 2026 - reported 29.01.26)

📈 Quarterly sales Q3:

~289.3 billion JPY (+11,4% YoY) → significant acceleration and outperformance compared to market expectations.

📊 9-month sales:

At JPY 834.6 billion (+7,7% YoY), the company is heading unerringly towards a new record year.

📈 Profitability:

Record operating margin (EBIT) of ~50% → An absolute peak value that makes Keyence look more like a software company than a hardware company.

👥 Regional dynamics:

The strong overseas business in particular (+13,3%) is driving growth and easily offsetting the temporary weakness in the Japanese domestic market.

💰 Capital strength:

Massive cash reserves and an equity ratio of >90% enable a significant increase in the dividend forecast for 2026.

Conclusion: Keyence delivers industrial perfection in numbers. While competitors struggle with fixed costs, Keyence scales through efficiency and desirability.

🟢 The opportunities

🟢 Structural labor shortage:

Global demographics are forcing companies to automate. Keyence is the natural beneficiary of the skills shortage in Japan, China and Europe.

🟢 AI & machine vision as a guarantee for growth:

New vision systems with AI support increase the value per installation (ARPU) and open up new markets in automated quality control.

🟢 Asset-light scaling:

During an economic upturn additional turnover flows almost 1:1 into the profit, as no expensive investments in own factories are necessary.

🟢 Global expansion:

The unique direct sales model still offers enormous potential for conquering traditional retail in the USA and South East Asia.

🔴 The risks

⚠️ Cyclical dependency:

Keyence depends on the investment cycles of the automotive and semiconductor industries. A global recession puts a direct brake on demand.

⚠️ Currency headwinds (yen):

As the majority of growth is generated outside Japan, a strong yen leads to negative translation effects. translation effects on earnings.

⚠️ China cluster risk:

A significant proportion of demand comes from China. Geopolitical
tensions or local phases of weakness have a direct impact on international momentum.

⚠️ Sporting assessment:

Quality has its price. The high
P/E RATIO leaves room for corrections in the event of the slightest operational disappointment or slower growth.

💡 Conclusion & outlook

Keyence is not a short-term hardware trade, but a structural bet on global automation of the next decade.

🔹 Short term:

Sensitive to the general valuation level (P/E ratio), global currency effects and market sentiment towards quality stocks.

🔹 Long-term:

ROI machine with a deep technological moatextreme pricing power and an operating marginthat is unparalleled worldwide.

🎯 Investment case:

Leverage on skills shortage + smart factory + AI sensor technology + maximum margin efficiency→ Structurally value-enhancing, operationally highly profitable, the gold standard for the portfolio in the long term.

💬 Community question:

👉 Japan's most profitable tech champion as a defensive anchor in the portfolio

or

👉 currently too expensive for a new entry at this P/E ratio?

I am curious about your assessment 👇

I actually had individual stocks like $6861 (+4,23%)
$6920
$7012 (+8,24%)
$2802 (+1,62%) on the screen. Why has it now become the $XNKY (+2,45%) become?

ETF instead of individual stocks:

Instead of having to choose between the Japanese tech giants, I wanted to reduce the complexity by adding the 225 largest stocks to my portfolio.

Momentum affinity:

Since I am a fan of momentum (also have Europe Momentum in the core), the price weighting of the Nikkei 225 suits me more than the classic market capitalization.

Although Japan is already included in the $FWRG (+1,48%) I am now deliberately overweighting it. I believe that Japan still has a lot of potential to develop.

My aim is to realize gains from my individual stocks such as $ASML (+3,73%) and $GOOGL (+3,67%) as soon as a return of 200% has been achieved. Then I take the stake out and shift into the ETFs. This is how I prepare myself for times when I have to worry less about my portfolio and it becomes a self-runner.

I've realized that I spend too much time on the stock market and I want to reduce that.

My core should consist of 75% in future

- $FWRG (+1,48%)

- $IEFM (+2,97%)

- $EQAC (+1,23%)

- $XNKY (+2,45%)

- $EWG2 (+1,79%)

- $BTC (-0,29%)

Satellite with the mentioned profits and individual assets or altcoins at 25%.

My USA share is currently 40%, Europe 16%, Asia 12%, gold 12%, crypto 8%. I have the rest in $XEON (+0%) lying around.

The USA share should not exceed 50%, as I believe in Europe, emerging markets and Japan.

Good morning,

I find Japanese companies and culture extremely exciting 🧐. During my research I came across Keyence $6861 (+4,23%) as there isn't much about it here yet, so I thought I'd summarize the points I found.

I hope that one or the other will be interested.

Activity:

• Globally positioned
• 250 offices worldwide in 46 countries
• More than 60% of sales are generated outside Japan.

Industry:

• Automation through integrated imaging in industry
• They are suppliers in the industry
• The business competes software with direct sales

product:

• You do not simply sell hardware but: "High end precision, fast integration, technical support"
• You produce your own products, leaving you with high margins of over 80%.

Customers:

• Chip manufacturers
• car manufacturers
• Medical and pharmaceutical industry
• Consumer goods
• Mechanical engineering
• Logistics

The P/E ratio is around 35, historically it is lower than in the past, the company is not valued favorably but rather fairly.

Anyone interested in a profitable company from Japan with high margins and a broad range of customers in almost every sector should take a look at the company.

This is not investment advice. I would like to hear your opinions and assessments.

I wanted to take a look at the back row of the space baggage and I noticed $SPIR (+5,94%) un $BKSY noticed. Still very small but exciting at first glance. 2026 is going to be great! I definitely have my savings plans with $9868 (+3,02%)
$HLMA (-1,08%) and $6861 (+4,23%) supplemented. Also with $TER (+5,93%)
$MOG.B (+4,35%) and $HXL (+2,87%)

let's see what happens

My ETF strategy: 3 ETFs as the core for long-term success

After a lot of thought, I have decided to make some changes. I have decided to split my monthly investments into three ETFs that offer a mix of growth, stability and income potential. From now on, I will invest €1000 per month in these three ETFs, with all dividends being automatically reinvested to maximize the compound interest effect.

1.

Fidelity Global Quality Income $FGEQ (+0,77%)

This ETF focuses on high-quality companies worldwide that pay stable dividends. It provides regular income streams and is less volatile than growth stocks. As I am looking for solid passive income over the long term, this ETF is an important part of my portfolio. All dividends from this ETF are reinvested to further grow the capital.

2.

VanEck Developed Markets Dividend $TDIV (+0,34%)

Similar to the Fidelity ETF, this one invests in high-dividend companies, but focuses on developed markets. The VanEck ETF helps me to diversify my portfolio even more broadly and ensures regular distributions, which are also reinvested. This allows me to use the dividends as a growth driver without them weighing on the portfolio.

3.

Nasdaq 100 ETF $CSNDX (+1,24%)

The Nasdaq 100 is my growth driver. It invests in the largest technology and growth companies in the US, which gives me strong leverage to the technology and innovation sector. While the Nasdaq 100 is more volatile than the S&P 500, the potential returns from the tech sector can be very rewarding over the long term. Again, all dividends are automatically reinvested to further increase the growth rate.

My strategy

With this combination of dividend and growth ETFs, I am aiming for a balanced portfolio that offers both stable income and long-term growth. I focus on a long-term investment strategy that grows regularly with monthly investments of €1000. The automatic reinvestment of dividends is intended to maximize the compound interest effect and thus allow the portfolio to grow continuously over the years.

Asia and emerging markets via individual shares

As I want to invest specifically in the Asian and emerging markets, I plan to cover the corresponding proportion via individual shares. I want to focus on high-quality companies that are growing strongly in these regions and offer good long-term earnings opportunities. My favorites: $6861 (+4,23%)
$TKOMY
$1211 (-1,64%)
$FLXI (+0,28%)

Individual shares - focus on quality

I currently own a lot of individual shares (some bought without a plan) and plan to reduce these to a maximum of 20 strong quality shares. I want to consolidate my portfolio and only invest in companies that have high growth and earnings potential and are robust enough to perform well even in difficult market phases.

Conclusion:

With this strategy of the 3 ETFs as core and a careful selection of 20 strong individual stocks, I want to build a well-diversified portfolio that not only provides stable income, but also benefits from global growth in the long term. By regularly investing €1000 per month and reinvesting all dividends, I aim to continuously grow my portfolio and achieve long-term financial security.

I would be delighted to hear your thoughts on my new strategy!

Have a great evening and a successful start to the new week!

LG your Max

September was a successful month - my securities account climbed to 38.827 € and gained +6,19 % significantly more than the major benchmarks (NASDAQ100: +4,94 %, S&P500: +3,19 %, FTSE All World: +3,23 %). I was thus able to clearly beat the market again. 🚀

1. performance & comparison 🚀

My portfolio benefited from a balanced mix: while individual techs performed well, other sectors provided additional stability. Particularly striking: the outperformance compared to the DAX & S&P, which were comparatively weak in September.

2. my savings plans & allocation 💶

As usual, my ETF savings plans continue to run consistently - with a focus on the solid foundation of MSCI ACWI $ACWI and World Small Cap $WSML (+1,52%). In addition, capital flows monthly into Berkshire Hathaway (B) $BRK.B (-0,04%) as a flexible, defensive allocation with optional cash flow leverage in a crash scenario.

In addition to the securities, I also invested € 180 in an original oil painting by Luciano Torsi in September - a small but deliberate step into alternative real assets. I am thus adding an aesthetic, real asset with long-term value retention potential to my allocation.

3rd top mover in September ✅

The list was headed by IREN $IREN (-0,52%) (+76%), which benefited from the strong demand for AI data centers. Also American Lithium (+36 %) also showed strength. Alibaba $Baba (+35 %) made significant gains thanks to cloud growth, in-house chip development and the rejection of NVIDIA chips. Rheinmetall $RHM (+7,69%) (+17 %) continued to benefit from high defense demand, while the uranium sector (+16 %) and Crowdstrike $CRWD (+0,16%) (+14 %) also performed well.

4th flop mover in September ❌

On the opposite side Snowflake
$SNOW (+2,16%) (-5%) lost some ground as investors became increasingly critical of its high valuation - despite solid figures. Also Mercado Libre
$MELI (-0,4%) (-4 %) also suffered from profit-taking after a strong summer rally. Keyence $6861 (+4,23%) (-3 %) and Tomra Systems $tomra (-2.8 %) corrected slightly without the fundamental picture deteriorating. The month was somewhat weaker for Novo Nordisk
$NOVO B (-0,26%) (-2.2 %), which continues to struggle with political risks and patent concerns in the GLP-1 segment. Even Berkshire Hathaway fell slightly (-1 %).

5. conclusion 💡

My September shows: Diversification pays off. Individual techs like Snowflake are correcting, but satellites like IREN and Alibaba are more than compensating for this. With the savings plan on Berkshire, I remain defensively prepared should volatility increase in Q4.

❓ Question for the community:

Which value surprised you the most in September - positive or negative?

👋 Hello dear getquin community,

First of all, I would like to thank you for your great support, including the many new followers. I am very pleased that my topics are so well received here and that the topic of humanoid robotics is getting so much attention. I would also like to thank everyone who has already contributed to my last posts, because your thoughts and discussions are really driving this exciting topic forward. @Multibagger
@Tenbagger2024

Today I'm focusing on a topic that Elon Musk recently described as the biggest challenge for humanoid robots: hands and gripping systems.

🔍 Focus: robot hands & gripping systems

I took a look at why hands are so complex for humanoid robots and read the research report from Nature Machine Intelligence under the microscope:

👉 Embedding high-resolution touch across robotic hands (Nature, 2025)

The study shows: Advances such as the F-TAC hand with high-resolution touch sensors are a huge step forward. But there are still 5 major challenges remain:

Tactile feedback / real "fingertip sensitivity" is often missing.

Mechanics vs. sensor integration / narrow design vs. flexible fingers.

Algorithms & data / Real-time control remains difficult.

Durability / Robot hands are often still too fragile.

Costs / Complex hands are extremely expensive.

🦾 Who is already working on this today?

Here is an overview of listed companies that play a role in the "hand problem":

⚙️ Actuators & Precision Gears

$6324 (+5,22%)
Harmonic Drive (JP) - Precision gears, almost standard in robot hands

$6481 (+8,8%)
THK (JP) - Linear guides & actuators

$6273 (+6,99%)
SMC Corp. (JP) - Mini actuators, pneumatics

👁️ Sensors & touch

$6861 (+4,23%)
Keyence (JP) - Force & vision sensors

$CGNX (+1,31%)
Cognex (US) - industrial image processing

$STM (-0,33%)
STMicroelectronics (FR/IT) - MEMS & pressure sensors

✋ Gripping systems & end effectors

$ABBN (+2,86%)
ABB (CH) - Industrial robots with gripping modules

$6954 (+3,73%)
Fanuc (JP) - Integrated grippers in robot platforms

$(Private, but important: Schunk, Festo - market leader for grippers)

🤖 End applications / developer of humanoid robots

$TSLA (+1,54%)
Tesla (US) - Optimus with focus on functional hands

$Neura Robotics (DE,private) - Cognitive humanoid robots with hand research

Agility Robotics (US, private) - humanoid robot "Digit" with gripping ability

Here is the full humanoid robot investment report

https://getqu.in/MBgIMg/

📌 Take-Away

Without functioning hands, humanoid robots remain limited. The combination of precision mechanics, sensor technology and control is the key and this is where there are exciting investment opportunities from Harmonic Drive to Tesla.

👉 Question for you: Do you think that in the next 5 years we will see robot hands that really achieve human dexterity or will this remain a dream of the future for even longer?

Image: © riko2022 - stock.adobe.com